Cargando…

What do people with type 2 diabetes want from a brief messaging system to support medication adherence?

BACKGROUND: Many people with type 2 diabetes do not take their treatment as prescribed. Brief messages to support medication use could reach large numbers of people at a very low cost per person, but current interventions using brief messages rarely adequately describe the content of the messages, n...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartlett, Yvonne Kiera, Newhouse, Nikki, Long, Hannah A, Farmer, Andrew J, French, David P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777899/
https://www.ncbi.nlm.nih.gov/pubmed/31686789
http://dx.doi.org/10.2147/PPA.S217843
_version_ 1783456681544384512
author Bartlett, Yvonne Kiera
Newhouse, Nikki
Long, Hannah A
Farmer, Andrew J
French, David P
author_facet Bartlett, Yvonne Kiera
Newhouse, Nikki
Long, Hannah A
Farmer, Andrew J
French, David P
author_sort Bartlett, Yvonne Kiera
collection PubMed
description BACKGROUND: Many people with type 2 diabetes do not take their treatment as prescribed. Brief messages to support medication use could reach large numbers of people at a very low cost per person, but current interventions using brief messages rarely adequately describe the content of the messages, nor base these messages on explicit behavior change principles. This study reports the views of people with type 2 diabetes concerning the acceptability of 1) a messaging system and 2) proposed messages based on behavior change techniques (BCTs) and beliefs and concerns around taking medication. METHODS: The proposed system and brief messages were discussed in focus groups of people with type 2 diabetes recruited through general practices in England. Transcripts were analyzed thematically. PARTICIPANTS: Twenty-three participants took part in one of five focus group discussions. All participants were over 18 years, were taking tablet medication for their diabetes, and had access to a mobile phone. Key exclusion criteria were recent hospitalization for hyper- or hypoglycemia or diagnosis with a terminal illness. RESULTS: Four themes were identified as relating to the acceptability of the messaging system: “opportunities and limitations of technology”, “us and them (who is the system for?)”, “responsibility for adherence”, and “diabetes management beyond medication”. Participants recognized the benefit of using technology. Those with high confidence in their ability to adhere were keen to make a distinction between themselves and those who did not adhere; participants were more comfortable taking responsibility for medication than diet and exercise. Acceptability of the messages hinged on avoiding “preaching to the converted”. CONCLUSIONS: These findings show that brief messaging could be acceptable to the target population for a range of diabetes-related behaviors but highlight the need for such a system to be perceived as personally relevant. Acceptable messages would need to maintain novelty for the target population.
format Online
Article
Text
id pubmed-6777899
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-67778992019-11-04 What do people with type 2 diabetes want from a brief messaging system to support medication adherence? Bartlett, Yvonne Kiera Newhouse, Nikki Long, Hannah A Farmer, Andrew J French, David P Patient Prefer Adherence Original Research BACKGROUND: Many people with type 2 diabetes do not take their treatment as prescribed. Brief messages to support medication use could reach large numbers of people at a very low cost per person, but current interventions using brief messages rarely adequately describe the content of the messages, nor base these messages on explicit behavior change principles. This study reports the views of people with type 2 diabetes concerning the acceptability of 1) a messaging system and 2) proposed messages based on behavior change techniques (BCTs) and beliefs and concerns around taking medication. METHODS: The proposed system and brief messages were discussed in focus groups of people with type 2 diabetes recruited through general practices in England. Transcripts were analyzed thematically. PARTICIPANTS: Twenty-three participants took part in one of five focus group discussions. All participants were over 18 years, were taking tablet medication for their diabetes, and had access to a mobile phone. Key exclusion criteria were recent hospitalization for hyper- or hypoglycemia or diagnosis with a terminal illness. RESULTS: Four themes were identified as relating to the acceptability of the messaging system: “opportunities and limitations of technology”, “us and them (who is the system for?)”, “responsibility for adherence”, and “diabetes management beyond medication”. Participants recognized the benefit of using technology. Those with high confidence in their ability to adhere were keen to make a distinction between themselves and those who did not adhere; participants were more comfortable taking responsibility for medication than diet and exercise. Acceptability of the messages hinged on avoiding “preaching to the converted”. CONCLUSIONS: These findings show that brief messaging could be acceptable to the target population for a range of diabetes-related behaviors but highlight the need for such a system to be perceived as personally relevant. Acceptable messages would need to maintain novelty for the target population. Dove 2019-09-30 /pmc/articles/PMC6777899/ /pubmed/31686789 http://dx.doi.org/10.2147/PPA.S217843 Text en © 2019 Bartlett et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Bartlett, Yvonne Kiera
Newhouse, Nikki
Long, Hannah A
Farmer, Andrew J
French, David P
What do people with type 2 diabetes want from a brief messaging system to support medication adherence?
title What do people with type 2 diabetes want from a brief messaging system to support medication adherence?
title_full What do people with type 2 diabetes want from a brief messaging system to support medication adherence?
title_fullStr What do people with type 2 diabetes want from a brief messaging system to support medication adherence?
title_full_unstemmed What do people with type 2 diabetes want from a brief messaging system to support medication adherence?
title_short What do people with type 2 diabetes want from a brief messaging system to support medication adherence?
title_sort what do people with type 2 diabetes want from a brief messaging system to support medication adherence?
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777899/
https://www.ncbi.nlm.nih.gov/pubmed/31686789
http://dx.doi.org/10.2147/PPA.S217843
work_keys_str_mv AT bartlettyvonnekiera whatdopeoplewithtype2diabeteswantfromabriefmessagingsystemtosupportmedicationadherence
AT newhousenikki whatdopeoplewithtype2diabeteswantfromabriefmessagingsystemtosupportmedicationadherence
AT longhannaha whatdopeoplewithtype2diabeteswantfromabriefmessagingsystemtosupportmedicationadherence
AT farmerandrewj whatdopeoplewithtype2diabeteswantfromabriefmessagingsystemtosupportmedicationadherence
AT frenchdavidp whatdopeoplewithtype2diabeteswantfromabriefmessagingsystemtosupportmedicationadherence